MedTech News
.................... by Andrew Celentano
PATHFINDER 2 findings advance multi-cancer early detection blood testing
A single blood draw that screens for more than 50 cancers substantially increased cancer detection when added to standard screening, identifying cancers that otherwise might have gone undetected until later stages, according to a new study from the Oregon Health & Science University Knight Cancer Institute.
SystImmune Receives FDA Clearance of IND Application for Bispecific Antibody SI-B037
Clearance marks SystImmune’s first IND enabled by pioneering New Approach Methodologies (NAMs), underscoring global innovation and translational leadership
AIMD Expands A-LRYNGO, the World’s First AI-Guided Video Laryngoscope, to Global Markets
SEOUL, South Korea, Sept. 22, 2026 /PRNewswire/ — AIMD Inc., a Korean medical technology company specializing in AI-powered emergency care, announced the global expansion of A-LRYNGO™, the world’s first AI-guided video laryngoscope with real-time automatic glottis recognition, as the company advances AI-guided airway management into clinical practice worldwide.
Mira Launches Cortisol Pattern™ Kit To Redefine Stress Tracking in Women’s Health
The first at-home urine test built to track stress patterns over time using a biological signal instead of a wearable estimate
Resivant Medical Receives U.S. Patent Protecting Novel Single-Lever, Single-Handed Applicator at the Core of the Cutiva™ PLUS Skin Closure System
AKRON, Ohio, Sept. 22, 2026 /PRNewswire/ — Resivant Medical announced today that the U.S. Patent and Trademark Office has issued Patent No. 12,678,148, covering the novel single-lever, single-handed applicator design at the core of the Cutiva™ PLUS Skin Closure System. The patent protects the mechanism that allows clinicians to start, control, and stop the flow of adhesive using a single lever, without repositioning the hand or device.
Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel
Pattern Bioscience, an Austin, Texas-based innovator in rapid diagnostic technologies for bacterial infections, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Urine ID/AST Panel. The panel is the company’s second assay to receive the designation, following the Pneumonia ID/AST Panel, reflecting Pattern’s continued focus on expanding a menu of rapid, direct-from-specimen assays.
Cordis earns FDA nod for Selution SLR drug-eluting balloon
Cordis earned FDA approval for its Selution SLR (sustained limus release) drug-eluting balloon (DEB) to treat coronary in-stent restenosis, the device developer announced today.
DePuy Synthes launches next-generation automated fracture fixation system
Johnson & Johnson MedTech’s DePuy Synthes Orthopaedics business launched its next-generation Maxframe Autostrut with Bluetooth Multi-Axial Correction System, the company announced today.